King Khalid Hospital

Narjan, Saudi Arabia

We are delighted to celebrate Dr. Salem Alobaiyah, Dr. Nasser Algharem, Mr. Dhafer Al Bahri, and the interventional oncology team at King Khalid Hospital on this significant achievement.

By meeting the requirements of the IASIOS accreditation programme, the team has demonstrated its commitment to advancing interventional oncology and embedding internationally recognised quality standards into its clinical practice. The implementation of the CIRSE Standards of Quality Assurance reflects a strong focus on clinical excellence, multidisciplinary collaboration, and the ongoing development of high-quality services.

This recognition highlights the department’s dedication to delivering safe, effective, and patient-centred image-guided cancer treatments, supported by robust quality assurance processes and a culture of continuous improvement. We are proud to welcome King Khalid Hospital to the IASIOS-accredited network and congratulate everyone involved in reaching this important milestone.

[/vc_column_text][/vc_column][/vc_row]

Thriasio General Hospital of Elefsina

Elefsina, Greece

IASIOS is pleased to welcome Thriasio General Hospital of Elefsina to its growing international network of centres committed to advancing quality in interventional oncology.

Joining IASIOS represents an important opportunity for the hospital to further develop its quality assurance processes, strengthen multidisciplinary collaboration, and support the delivery of safe, high-quality patient care. We would like to recognise Dr. Panagiotis Keneth Papaspyridakos Papadakos, Mrs. Evangelia Triantafyllou, and the entire team for their engagement and commitment to taking this step towards internationally recognised standards.

We look forward to working together with Thriasio General Hospital of Elefsina and supporting the team throughout their journey towards IASIOS accreditation.

WEGE Klinik

Bonn, Germany

We are delighted to welcome WEGE Klinik to the IASIOS network as a newly enrolled centre.

By embarking on the IASIOS accreditation journey, the centre demonstrates its dedication to advancing quality and patient safety in interventional oncology. We congratulate Prof. Dr. Attila Kovács, Dr. Peter Bischoff, and the entire team on taking this important step towards further strengthening clinical standards and fostering a culture of continuous quality improvement.

We look forward to supporting WEGE Klinik throughout its journey towards IASIOS accreditation and to following its continued development in interventional oncology.

CHU François-Mitterrand Dijon Bourgogne

Dijon, France

We are pleased to announce that CHU François-Mitterrand Dijon Bourgogne has joined IASIOS as an Enrolled Centre.

This step reflects the centre’s commitment to strengthening patient safety and clinical quality in interventional oncology. We commend Prof. Romaric Loffroy, Dr. Olivier Chevallier, and the entire team for their leadership in undertaking the IASIOS accreditation journey and their continued commitment to high-quality, patient-centred care.

We look forward to supporting CHU François-Mitterrand Dijon Bourgogne on its path towards IASIOS accreditation.

Interventional Radiology Center

Yerevan, Armenia

A warm welcome to the Interventional Radiology Center in Armenia, which has joined IASIOS as a newly enrolled centre.

This important step reflects the team’s commitment to strengthening the quality and delivery of interventional oncology services, while further developing structured clinical pathways and a collaborative, multidisciplinary approach to cancer care.

By engaging with IASIOS, the centre will have the opportunity to align its practices with internationally recognised quality standards and embed continuous quality improvement across its interventional oncology services.

As a new member of the IASIOS network, the Interventional Radiology Center in Armenia joins an international community of centres working to advance quality, safety, and excellence in image-guided cancer care.

We are delighted to accompany the team on this journey and support their continued progress toward IASIOS accreditation.

Hospital Italiano de Buenos Aires

Buenos Aires, Argentina

We are delighted to welcome Hospital Italiano de Buenos Aires as a newly enrolled centre in the IASIOS network.

By taking this important step, the team is demonstrating its commitment to the continued development of interventional oncology, with a focus on strengthening clinical pathways, multidisciplinary collaboration, and a culture of quality assurance and continuous improvement.

Through engagement with IASIOS, Hospital Italiano de Buenos Aires will work toward harmonising practices with internationally recognised standards, supporting the delivery of high-quality, patient-centred cancer care.

The centre now joins a growing global community of institutions dedicated to advancing quality and excellence in interventional oncology.

IASIOS is pleased to support the team throughout this journey and looks forward to accompanying them on their path toward full accreditation.

Queen Elizabeth Hospital

Hong Kong, Hong Kong

A warm welcome to Queen Elizabeth Hospital, which has joined IASIOS as a newly enrolled centre.

By embarking on this journey, the team is making a meaningful investment in the continued development of interventional oncology, with a focus on well-defined clinical pathways, multidisciplinary collaboration, and a strong culture of quality assurance. Engagement with IASIOS will support the team in working toward harmonised practices and internationally recognised standards, while fostering continuous quality improvement in cancer care.

Queen Elizabeth Hospital now becomes part of a growing global network of centres dedicated to advancing quality and excellence in interventional oncology.

IASIOS is delighted to accompany the team throughout this journey and support their progress toward full accreditation.

Stadtspital Zürich

Zürich, Switzerland

It is our pleasure to announce Stadtspital Zürich as the latest centre to embark on the IASIOS journey as a newly enrolled centre.

This important step demonstrates the institution’s commitment to further strengthening interventional oncology through robust clinical pathways and a culture of quality assurance. By engaging with IASIOS, the team is taking steps toward aligning its practices with international standards, while promoting collaboration across the multidisciplinary teams involved in cancer care.

Stadtspital Zürich now joins centres from around the world that share a commitment to continuously improving the quality and delivery of interventional oncology services.

IASIOS is proud to support the team on this journey and looks forward to accompanying them toward full accreditation.

Aarhus University Hospital

Aarhus, Denmark

We are delighted to welcome Aarhus University Hospital to the growing IASIOS network as a newly enrolled centre.

This enrolment represents an important step in strengthening the future of interventional oncology at the institution, supporting the development of well-defined clinical pathways and a strong culture of quality assurance. Through engagement with IASIOS, the team is working toward aligning practices with internationally recognised standards while encouraging collaboration across the specialties involved in cancer care.

Aarhus University Hospital now joins a diverse international community of centres committed not only to maintaining high standards, but to continuously developing and improving them.

IASIOS is pleased to accompany the team on this journey and support their progress toward full accreditation.

Hunter New England Medical Imaging

New Lambton Heights, Australia

A warm congratulations to Dr. Christian Abel, Dr. Michael Carey, and the interventional oncology team at Hunter New England Medical Imaging on becoming part of the IASIOS-accredited network.

This accomplishment reflects the team’s dedication to establishing and maintaining high standards in interventional oncology. By aligning their clinical practices with the CIRSE Standards of Quality Assurance, the team has demonstrated a clear commitment to patient safety, multidisciplinary collaboration, and the continuous advancement of their services.

Through this achievement, Hunter New England Medical Imaging reinforces its commitment to delivering high-quality, safe, and effective image-guided cancer therapies, with patients at the centre of care. We are delighted to recognise the team’s efforts and congratulate Dr. Abel, Dr. Carey, and all those involved on reaching this important milestone